McKinnon et al report that tertiary care centers have the best results
This test evaluates how your body responds to GLP-1 receptor signaling and other peptide pathways, informing whether semaglutide alone, combination therapy with metformin, or alternative compounds like tirzepatide may serve you best
MorieriMLTargherGLapollaAD'AmbrosioMTadiottoFRigatoMet al
"Phospholipase C, Phosphatidylinositol-specific from Bacillus cereus" (PDF)
New evidence shows that GLP-1based therapies not only lower glucose levels and aid in weight loss but also reduce inflammation in the heart, kidneys, liver, and brain, revealing a broader therapeutic potential beyond metabolism
Luciani, P., Fibbi, B., Mazzanti, B., Deledda, C., Ballerini, L., Aldinucci, A., et al